Patents by Inventor Philippe Lluel

Philippe Lluel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Differentiating Epithelial Stem Cells
    Publication number: 20220340881
    Abstract: The subject matter of the present invention is a method for differentiating epithelial stem cells, comprising culturing one or more epithelial stem cells in contact with an extracellular matrix in the presence of an expansion medium, a bovine pituitary extract, a receptor tyrosine kinase ligand, a supernatant of primary fibroblasts and optionally, a Rho kinase inhibitor.
    Type: Application
    Filed: August 7, 2020
    Publication date: October 27, 2022
    Inventors: PHILIPPE LLUEL, NATHALIE VERGNOLLE, XAVIER GAME, CELINE ROUGET, MORGANE SÉBERT
  • Incontinence treatment methods
    Patent number: 9511061
    Abstract: The invention relates to the fields of pharmaceutical chemistry and pharmacological treatments. More specifically, the invention relates to compositions and methods for the treatment of incontinence, voiding disorders associated with lower urinary tract dysfunctions and/or the urethro-vesical and anal sphincteral disorders. The invention can be used, for example, for the treatment of pollakiuria, urinary urgency, nocturia or enuresis, true faecal incontinence, functional faecal incontinence (FFI), passive faecal incontinence, faecal urgency and/or faecal seepage. The invention is suitable for preventive or curative use with all mammals, particularly humans.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: December 6, 2016
    Assignee: IXALTIS
    Inventors: Philippe Lluel, Stefano Palea
  • NEW COMBINATION OF ACTIVE INGREDIENTS CONTAINING AN a1-ANTAGONIST AND A PDE 4 INHIBITOR
    Publication number: 20110263621
    Abstract: The subject of the present invention is a new combination of active ingredients consisting of alfuzosin and PDE 4 inhibitor, and pharmaceutical compositions containing them, for ameliorating and/or treating benign prostatic hyperplasia, urinary disorders, disorders related to bladder dysfunction, lower urinary tract symptoms associated or not associated with benign prostatic hyperplasia, urinary incontinence, bladder outlet obstruction associated or not associated with benign prostatic hyperplasia, interstitial cystitis and overactive bladder.
    Type: Application
    Filed: August 17, 2009
    Publication date: October 27, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Philippe Lluel, Stefano Palea, Maurice Sofeir
  • Incontinence Treatment Methods
    Publication number: 20080305162
    Abstract: The invention relates to the fields of pharmaceutical chemistry and pharmacological treatments. More specifically, the invention relates to compositions and methods for the treatment of incontinence, voiding disorders associated with lower urinary tract dysfunctions and/or the urethro-vesical and anal sphincteral disorders. The invention can be used, for example, for the treatment of pollakiuria, urinary urgency, nocturia or enuresis, true faecal incontinence, functional faecal incontinence (FFI), passive faecal incontinence, faecal urgency and/or faecal seepage. The invention is suitable for preventive or curative use with all mammals, particularly humans.
    Type: Application
    Filed: December 20, 2006
    Publication date: December 11, 2008
    Inventors: Philippe Lluel, Stefano Palea